Macular telangiectasia

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
S Ophthalmology/ENT (ATC S) 1
Mechanism of action (INN-stem analysis)
Receptor fusion protein 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Centre Hospitalier Universitaire De Dijon Academic
    AFLIBERCEPT
    2024-511885-35-00 1 country 2019 n=46
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Centre Hospitalier Universitaire De Dijon Academic 1 Phase III 0
New trials by year
2019
1
← All indication landscapes